Systemic vasculitis with severe cutaneous manifestation as a suspected idiosyncratic hypersensitivity reaction to fenbendazole in a cat.
Jasani
S
S
Queen Mother Hospital for Animals, Veterinary Clinical Sciences, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, UK. sjasani@rvc.ac.uk
Boag
A K
AK
Smith
K C
KC
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D002371:Cat Diseases / Q000139:chemically induced* / Q000473:pathology; D002415:Cats; D002699:Chlorambucil / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000150:complications / Q000473:pathology / Q000662:veterinary*; D004431:Ear, External / Q000473:pathology; D005260:Female; D005273:Fenbendazole / Q000009:adverse effects*; D005528:Foot / Q000473:pathology; D006400:Hematocrit / Q000662:veterinary; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010431:Pentoxifylline / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D013623:Tail / Q000473:pathology; D014657:Vasculitis / Q000139:chemically induced / Q000473:pathology / Q000662:veterinary*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D002699:Chlorambucil; D005273:Fenbendazole; D011239:Prednisolone; D010431:Pentoxifylline